These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6160089)

  • 1. Different serum requirements for opsonization of two serologically identical strains of Pseudomonas aeruginosa.
    Ogle CK; Ogle JD; Stinnett JD; Stace P; Alexander JW
    Immunol Commun; 1980; 9(7):677-91. PubMed ID: 6160089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-mediated phagocytosis of Pseudomonas aeruginosa.
    Peterson PK; Kim Y; Schmeling D; Lindemann M; Verhoef J; Quie PG
    J Lab Clin Med; 1978 Dec; 92(6):883-94. PubMed ID: 105067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative method for assessing the third complement factor (C3) attached to the surface of opsonized Pseudomonas aeruginosa: interrelationship between C3 fixation, phagocytosis and complement consumption.
    Engels W; Endert J; Van Boven CP
    J Immunol Methods; 1985 Jul; 81(1):43-53. PubMed ID: 3926902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opsonization and phagocytosis of mucoid and non-mucoid Pseudomonas aeruginosa strains.
    Meshulam T; Verbrugh HA; Verhoef J
    Eur J Clin Microbiol; 1982 Apr; 1(2):112-7. PubMed ID: 6816585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization.
    Van Dijk WC; Verbrugh HA; van der Tol ME; Peters R; Verhoef J
    Infect Immun; 1979 Aug; 25(2):603-9. PubMed ID: 385502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of complement in the opsonization of mucoid and non-mucoid strains of Pseudomonas aeruginosa.
    Baltimore RS; Shedd DG
    Pediatr Res; 1983 Dec; 17(12):952-8. PubMed ID: 6419197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsonization of mucoid and non-mucoid Pseudomonas aeruginosa by serum from patients with cystic fibrosis assessed by a chemiluminescence assay.
    LeBlanc CM; Bortolussi R; Issekutz AC; Gillespie T
    Clin Invest Med; 1982; 5(2-3):125-8. PubMed ID: 6811181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opsonization of four Bacteroides species: role of the classical complement pathway and immunoglobulin.
    Tofte RW; Peterson PK; Schmeling D; Bracke J; Kim Y; Quie PG
    Infect Immun; 1980 Mar; 27(3):784-92. PubMed ID: 6103873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic investigations of mucoid strains of Pseudomonas aeruginosa: comparison of susceptibility to opsonic antibody in mucoid and nonmucoid strains.
    Baltimore RS; Mitchell M
    J Infect Dis; 1980 Feb; 141(2):238-47. PubMed ID: 6444976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phagocytosis and killing of Pseudomonas aeruginosa by mouse polymorphonuclear leukocytes in vitro promoted by antiserum to the slime glycolipoprotein.
    Bishop O; Orr T; Bartell PF
    Infect Immun; 1982 Jul; 37(1):378-81. PubMed ID: 6809634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of subinhibitory concentrations of antibiotics on opsonization and phagocytosis of Pseudomonas aeruginosa by human polymorphonuclear leukocytes.
    Milatovic D
    Eur J Clin Microbiol; 1984 Aug; 3(4):288-93. PubMed ID: 6436020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum factors capable of opsonizing Shigella for phagocytosis by polymorphonuclear neutrophils.
    Reed WP
    Immunology; 1975 Jun; 28(6):1051-9. PubMed ID: 1132888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for quantitative variability of bacterial opsonic requirements.
    Guckian JC; Christensen WD; Fine DP
    Infect Immun; 1978 Mar; 19(3):822-6. PubMed ID: 25243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opsonization of group B streptococci in properdin deficient serum.
    Söderström C; Braconier JH; Christensen KK; Christensen P; Sjöholm AG
    Acta Pathol Microbiol Immunol Scand C; 1985 Dec; 93(6):251-6. PubMed ID: 3915179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The opsonic activity of stored blood.
    McClellan MA; Alexander JW
    Transfusion; 1977; 17(3):227-32. PubMed ID: 405758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of immunoglobulins M and G, complement, and properdin to the intracellular killing of Escherichia coli by polymorphonuclear leukocytes.
    Menzel J; Jungfer H; Gemsa D
    Infect Immun; 1978 Feb; 19(2):659-66. PubMed ID: 344218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors in human serum promoting phagocytosis of Pseudomonas aeruginosa. I. Interaction of opsonins with the bacterium.
    Bjornson AB; Michael JG
    J Infect Dis; 1974 Nov; 130 Suppl(0):S119-26. PubMed ID: 4214223
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay.
    Matthay KK; Mentzer WC; Wara DW; Preisler HK; Lameris NB; Ammann AJ
    Infect Immun; 1981 Jan; 31(1):228-35. PubMed ID: 7216447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opsonization of Legionella pneumophila in human serum: key roles for specific antibodies and the classical complement pathway.
    Verbrugh HA; Lee DA; Elliott GR; Keane WF; Hoidal JR; Peterson PK
    Immunology; 1985 Apr; 54(4):643-53. PubMed ID: 3980045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bactericidal, bacteriolytic and opsonic activity of human serum against Escherichia coli.
    Rozenberg-Arska M; Porsius JC; Jaarsma EY; Verhoef J
    J Med Microbiol; 1986 Sep; 22(2):143-9. PubMed ID: 3528498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.